Journal Information
Vol. 101. Issue 8.
Pages 657-658 (October 2010)
Vol. 101. Issue 8.
Pages 657-658 (October 2010)
Opinion article
Full text access
Nonalcoholic Fatty Liver Disease and Psoriasis
Hígado graso no alcohólico y psoriasis
Visits
5945
Servicio de Dermatología, Hospital Universitario 12 De Octubre, Madrid, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
C.E. Griffiths, J.N. Barker.
Pathogenesis and clinical features of psoriasis.
Lancet, 370 (2007), pp. 263-271
[2.]
D.M. Sommer, S. Jenisch, M. Chuman, E. Christophers, M. Weichenthal.
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
Arch Dermatol Res, 298 (2006), pp. 321-328
[3.]
L.A. Adams, P. Angulo, K.D. Lindor.
Nonalcoholic fatty liver disease.
CMAJ, 172 (2005), pp. 899-905
[4.]
G.N. Ioannou, E.J. Boyko, S.P. Lee.
The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002.
Am J Gastroenterol, 101 (2006), pp. 76-82
[5.]
L.A. Adams, S. Sanderson, K. Lindor, P. Angulo.
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
J Hepatol, 42 (2005), pp. 132-138
[6.]
M. Ekstedt, L.E. Franzén, U.L. Mathiesen, L. Thorelius, M. Holmqvist, G. Bodemar, et al.
Long-term follow-up of patients with NAFLD and elevated liver enzymes.
Hepatology, 44 (2006), pp. 865-873
[7.]
A. Lonardo, P. Loria, N. Carulli.
Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI. ST. E. N. A. study.
Dig Liver Dis, 33 (2001), pp. 86-87
[8.]
P. Gisondi, G. Targher, G. Zoppini, G. Girolomoni.
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
J Hepatol, 51 (2009), pp. 758-764
[9.]
L. Miele, S. Vallone, C. Cefalo, G. La Torre, C. Di Stasi, F.M. Vecchio, et al.
Prevalence, characteristic and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
J Hepatol, 51 (2009), pp. 778-786
[10.]
E. Christophers.
Comorbidities in psoriasis.
Clin Dermatol, 25 (2007), pp. 529-534
[11.]
M. Sumarac-Dumanovic, D. Stevanovic, A. Ljubic, J. Jorga, M. Simic, D. Stamenkovic-Pejkovic, et al.
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women.
Int J Obes (Lond), 33 (2009), pp. 151-156
[12.]
Wolf-Henning Boehncke. Oral presentation: 3rd Faculty Update Meeting PEARLS. Dusseldorf, 2010.
Copyright © 2010. Academia Española de Dermatología y Venereología and Elsevier España, S.L.